Novartis to close Puerto Rico plant and outsource to Eli Lilly
Novartis will close an OTC plant in Puerto Rico by 2019 and transfer manufacturing and packaging actives to sites in the US and facilities operated by Eli Lilly and Virbac.
Archives for January 19, 2015
Novartis-Qualcomm deal leads race to bring wearable tech to pharma
Big pharma and CROs looking to exploit wearable technology in clinical trials will need to overcome reliability and regulatory problems, says an expert.
Cost, not compliance, behind Clayton closure, says Hospira
Hospira has announced it will close its plant in Clayton, North Carolina that it no longer deems cost effective for drug production.
MannKind: Small step for delivery tech R&D after Afrezza's giant leap
MannKind’s development of new drugs with the delivery technology used in its inhalable insulin drug Afrezza will progress without founder Alfred Mann at the helm.
J&J to receive almost €50m in grants to help manufacture Ebola vaccines
EFPIA has given J&J subsidiary Crucell Holland and partner Bavarian Nordic €47.6m ($54.9m) to accelerate development of an candidate Ebola vaccine.